CLINICAL_TRIALS
research
· 2026-04-07
Clinical Trial Update: A Study of E6742 in Participants With Systemic Lupus Erythematosus [Phase 2]
Summary
A Phase 2 clinical trial evaluating E6742 for systemic lupus erythematosus is listed as not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: NOT_YET_RECRUITING